These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8113327)

  • 21. [Difference in the distribution of 123I-IMP and 99mTc-HMPAO in the striatum--comparison with 15O-PET].
    Otsuka M; Ichiya Y; Kuwabara Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K
    Kaku Igaku; 1993 Apr; 30(4):389-95. PubMed ID: 8315889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative 123I IMP and 99mTc HMPAO imaging in the dog following cocaine administration.
    Susskind H; Weber DA; Ivanovic M; Wong CT; DeHaan CE; Gavin PR
    Nucl Med Biol; 1996 Apr; 23(3):343-52. PubMed ID: 8782246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased uptake of 99mTc-HMPAO in necrotic brain tumors.
    Lee SH; Choi CW; Kim JH; Rhee CH; Lim SM
    J Korean Med Sci; 1998 Oct; 13(5):529-32. PubMed ID: 9811184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stabilization of [99mTc]HMPAO--1. Ethanolic preparation.
    Billinghurst MW; Abrams DN; Lawson MS
    Int J Rad Appl Instrum A; 1991; 42(7):607-12. PubMed ID: 1663094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The assessment of 99mTc-HMPAO tumor scintigraphy using VX-2 tumors in rabbits].
    Suga K; Uchisako H; Honma Y; Kuramitsu T; Itoh K; Nakagi K; Tanaka N; Ariyoshi I; Nakanishi T; Utsumi H
    Kaku Igaku; 1991 Sep; 28(9):1049-56. PubMed ID: 1770657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of ligand structure on glutathione-mediated decomposition of propylene amine oxime derivatives.
    Roth CA; Hoffman TJ; Corlija M; Volkert WA; Holmes RA
    Int J Rad Appl Instrum B; 1992 Oct; 19(7):783-90. PubMed ID: 1399700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pulmonary clearance of 99mTc-HMPAO aerosol].
    Kawakami K; Tominaga S; Takagi H; Mori Y; Gotou E; Iwamura A; Shimada T
    Kaku Igaku; 1990 May; 27(5):451-7. PubMed ID: 2395228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical assessment of 99mTc-HMPAO scintigraphy in thoracic tumors].
    Suga K; Kawamura M; Nishigauchi K; Yoneshiro S; Fujita T; Ohno Y; Matsumoto T; Nakanishi T; Utsumi H; Yamada N
    Kaku Igaku; 1992 Sep; 29(9):1143-9. PubMed ID: 1453565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technetium-99m-meso-HMPAO as a potential agent to image cerebral glutathione content.
    Sasaki T; Senda M
    J Nucl Med; 1997 Jul; 38(7):1125-9. PubMed ID: 9225804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of technetium 99m cyclobutylpropylene amine oxime as a potential brain perfusion imaging agent for SPET.
    Bacciottini L; Lunghi F; Pupi A; Bonino C; Formiconi AR; De Cristofaro MT; Petti AR; Meldolesi U
    Eur J Nucl Med; 1990; 17(5):242-7. PubMed ID: 2083559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Astrocytes as a predominant cellular site of (99m)Tc-HMPAO retention.
    Zerarka S; Pellerin L; Slosman D; Magistretti PJ
    J Cereb Blood Flow Metab; 2001 Apr; 21(4):456-68. PubMed ID: 11323531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Technetium-99m-HMPAO cerebral perfusion scintigraphy: considerations for timely brain death declaration.
    Larar GN; Nagel JS
    J Nucl Med; 1992 Dec; 33(12):2209-11. PubMed ID: 1460517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of meningioma with non-accumulation of 99mTc-ECD and increased accumulation of 99mTc-HMPAO in the tumor].
    Kashimada A; Machida K; Honda N; Mamiya T; Takahashi T; Kamano T; Muramatsu M; Inoue Y
    Kaku Igaku; 1992 Sep; 29(9):1127-31. PubMed ID: 1453563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The utility of [99mTc]HMPAO-leukocytes for imaging infection.
    Peters AM
    Semin Nucl Med; 1994 Apr; 24(2):110-27. PubMed ID: 8023168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stabilisation of high-activity 99mTc-d,l-HMPAO preparations with cobalt chloride and their biological behaviour.
    Mang'era KO; Vanbilloen HP; Schiepers CW; Verbruggen AM
    Eur J Nucl Med; 1995 Oct; 22(10):1163-72. PubMed ID: 8542901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased 99mTc-HMPAO uptake in ischemic stroke.
    Baird AE; Donnan GA
    Stroke; 1993 Aug; 24(8):1261-2. PubMed ID: 8342204
    [No Abstract]   [Full Text] [Related]  

  • 37. Is 99Tcm hexamethyl-propyleneamine oxime uptake in the tissues related to glutathione cellular content?
    el-Shirbiny AM; Sadek S; Owunwanne A; Yacoub T; Suresh L; Abdel-Dayem HM
    Nucl Med Commun; 1989 Dec; 10(12):905-11. PubMed ID: 2622593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accumulation of 99mTc-HMPAO and 99mTc-ECD in rodent and human breast tumor cell lines in vitro.
    Ballinger JR; Duncan J; Hua HA; Ichise M
    Ann Nucl Med; 1997 May; 11(2):95-9. PubMed ID: 9212888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of flow and rate constants in a kinetic model of [99mTc]-hexamethyl-propylene amine oxime in the human brain.
    Matsuda H; Oba H; Seki H; Higashi S; Sumiya H; Tsuji S; Terada H; Imai K; Shiba K; Mori H
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S61-8. PubMed ID: 3192643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The radiation dosimetry and normal value study of 99mTc-HMPAO-labeled leukocytes.
    Brown ML; Hung JC; Vetter RJ; O'Connor MK; Chowdhury S; Forstrom LA
    Invest Radiol; 1994 Apr; 29(4):443-7. PubMed ID: 8034450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.